Giustina, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 201
EU - Europa 157
AS - Asia 82
SA - Sud America 23
AF - Africa 2
Totale 465
Nazione #
US - Stati Uniti d'America 198
IT - Italia 59
SG - Singapore 38
CN - Cina 30
SE - Svezia 27
BR - Brasile 21
DE - Germania 18
FR - Francia 16
IE - Irlanda 11
RU - Federazione Russa 8
ID - Indonesia 7
GB - Regno Unito 5
BE - Belgio 4
FI - Finlandia 4
AT - Austria 3
CA - Canada 2
CO - Colombia 2
KR - Corea 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
HK - Hong Kong 1
LI - Liechtenstein 1
MA - Marocco 1
MX - Messico 1
Totale 465
Città #
Chandler 54
Singapore 24
Ashburn 17
Rome 15
New York 10
Dublin 9
Milan 9
Lauterbourg 8
Fairfield 7
Jakarta 7
San Mateo 7
Boston 6
Bremen 6
Princeton 6
Los Angeles 5
Piacenza 5
Wilmington 5
Brussels 4
Cambridge 4
Frankfurt am Main 4
Moscow 4
Campobasso 3
Dalmine 3
Hefei 3
Helsinki 3
Marseille 3
Paris 3
Petrozavodsk 3
Washington 3
Ann Arbor 2
Augusta 2
Bogotá 2
Cesa 2
Cuiabá 2
Fuzhou 2
Guangzhou 2
Lahore 2
London 2
Menlo Park 2
Monreale 2
Montreal 2
Portsmouth 2
Seattle 2
Seoul 2
Vienna 2
Abidjan 1
Apiacá 1
Araponga 1
Arujá 1
Boardman 1
Brasília 1
Cazzago San Martino 1
Cleveland 1
Colinas 1
Conceição do Mato Dentro 1
Croydon 1
Dourados 1
Düsseldorf 1
Goiânia 1
Gunzenhausen 1
Hong Kong 1
Houston 1
Jatai 1
Lappeenranta 1
Leawood 1
Maceió 1
Mexico City 1
Monmouth Junction 1
Mountain View 1
Munich 1
Nanjing 1
Nanning 1
North Bergen 1
Norwalk 1
Nova Iguaçu 1
Porto Alegre 1
Quixadá 1
Redmond 1
Ribeirão Preto 1
Rio Branco 1
San Francisco 1
San Jose 1
Santa Clara 1
Schaan 1
Shenyang 1
São João do Manhuaçu 1
Taubaté 1
The Dalles 1
Timbó 1
Votorantim 1
Woodbridge 1
Xiangtan 1
Yerevan 1
Zurich 1
Totale 321
Nome #
The Changing Clinical Spectrum of Hypophysitis 106
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 100
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 67
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 61
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 58
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 51
Guidelines for acromegaly management: An update 20
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 12
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 6
Vitamin D in pituitary driven osteopathies 5
Totale 486
Categoria #
all - tutte 2.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 3 0 2 0
2021/202268 0 0 0 1 18 13 0 11 3 1 6 15
2022/2023172 17 18 13 24 7 53 4 12 17 1 2 4
2023/202481 1 13 4 11 5 17 2 2 1 1 14 10
2024/2025160 4 2 9 11 15 4 2 5 25 29 38 16
Totale 486